This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Allstate Q2 Earnings Beat Estimates on Strong Premium Growth
by Zacks Equity Research
ALL posts a massive Q2 earnings beat as premium growth, strong investments and lower costs drive a sharp profit surge.
Aon Q2 Earnings Surpass Estimates on Solid Retention Rates
by Zacks Equity Research
AON posts 19% y/y EPS growth in Q2, fueled by strong retention, NFP synergies and rising free cash flow.
AMERISAFE Q2 Earnings Miss Estimates on Lower Underwriting Profit
by Zacks Equity Research
AMSF's Q2 earnings miss estimates as lower underwriting profit and weaker investment income weigh on results.
Will Marex Group PLC (MRX) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Marex Group PLC (MRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Synchrony Q2 Earnings Beat Estimates on Improved Efficiency
by Zacks Equity Research
SYF's Q2 EPS tops estimates by 45% as efficiency gains, margin improvement and lower credit losses fuel profits.
American Express Q2 Earnings Beat Estimates on Premium Customers
by Zacks Equity Research
AXP's Q2 earnings jump 17% to beat estimates, fueled by premium customers and rising card fees despite higher costs.
Best Value Stocks to Buy for July 17th
by Zacks Equity Research
MRX and FCF made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 17, 2025.
Implied Volatility Surging for Marex Group Stock Options
by Zacks Equity Research
Investors need to pay close attention to MRX stock based on the movements in the options market lately.
Wall Street Analysts Believe Marex Group PLC (MRX) Could Rally 30.56%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 30.6% upside potential for Marex Group PLC (MRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Marex Group PLC (MRX) Upgraded to Buy: Here's Why
by Zacks Equity Research
Marex Group PLC (MRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stock to Buy for May 30th
by Zacks Equity Research
MRX, BIRK and DB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 30, 2025.
New Strong Buy Stocks for May 30th
by Zacks Equity Research
GLDD, DX, MRX, GNTY and STN have been added to the Zacks Rank #1 (Strong Buy) List on May 30, 2025.
Top Stock Picks for Week of May 19, 2025
by Panel Of Zacks Experts
A Business Services Stock That's Outperformed the Sector So Far This Year and a Financial Services Stock Showing Price Strength.
5 Stocks With Recent Price Strength to Maximize Your Gains
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ODD, CRS, HRTG, APH, MRX.
Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI
by Zacks Equity Research
Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI are part of the Zacks Screen of the Week article.
5 Stocks With Recent Price Strength Amid Tariff-Led Volatility
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are HRTG, MRX, KINS, ANIP, HCI.
Best Momentum Stocks to Buy for April 15th
by Zacks Equity Research
HSAI, BYRN and MRX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 15, 2025.
New Strong Buy Stocks for April 15th
by Zacks Equity Research
HSAI, LION, BBSEY, MRX and BYRN have been added to the Zacks Rank #1 (Strong Buy) List on April 15, 2025.
Best Income Stocks to Buy for April 15th
by Zacks Equity Research
BBSEY, MRX and HSBC made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 15, 2025.
Trading Near 52-Week High, Why GL Stock is Still Worth Buying Now
by Zacks Equity Research
Globe Life gains from premium growth, higher invested assets and a strong liquidity position. Escalating expenses and high leverage are major concerns.
Marex Group PLC (MRX) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Marex Group PLC (MRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Value Stocks to Buy for March 13th
by Zacks Equity Research
ENS, IBCP and MRX made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 13, 2025.
Implied Volatility Surging for Marex Group (MRX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Marex Group (MRX) stock based on the movements in the options market lately.
GL Rises 2.5% in 3 Months but Lags Industry: How to Play the Stock
by Zacks Equity Research
Globe Life gains from premium growth, higher invested assets and a strong liquidity position. Escalating expenses and high leverage are major concerns.
New Strong Buy Stocks for December 3rd
by Zacks Equity Research
RSI, BOW, ZION, PCB and MRX have been added to the Zacks Rank #1 (Strong Buy) List on December 3, 2024.